{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:17:37Z","timestamp":1790360257233,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jpba.2024.116100","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T21:21:02Z","timestamp":1709932862000},"page":"116100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["NPS\u2013EQA PART II: Four years\u2019 experience in external quality assessment program in Italy for classical and new psychoactive substances analysis in hair"],"prefix":"10.1016","volume":"243","author":[{"given":"Maria Concetta","family":"Rotolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Var\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Minutillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Di Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Aquilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Marchei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116100_bib1","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.3390\/ijerph20054628","article-title":"Challenges in drug surveillance: strengthening the analysis of new psychoactive substances by harmonizing drug checking services in proficiency testing","volume":"20","author":"Balcaen","year":"2023","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"10.1016\/j.jpba.2024.116100_bib3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/dta.310","article-title":"Social, policy, and public health perspectives on new psychoactive substances","volume":"3","author":"Sumnall","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116100_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3389\/fphar.2017.00785","article-title":"European Drug Users at Risk from Illicit Fentanyls Mix","volume":"8","author":"Pichini","year":"2017","journal-title":"Front Pharm."},{"key":"10.1016\/j.jpba.2024.116100_bib5","article-title":"New psychoactive substances: A review and updates","volume":"10","author":"Shafi","year":"2020","journal-title":"Adv. Psychopharmacol."},{"key":"10.1016\/j.jpba.2024.116100_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jpba.2018.10.011","article-title":"Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices","volume":"163","author":"Graziano","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116100_bib7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2174\/1570159X1709190729101751","article-title":"New Psychoactive Substances: A Matter of Time","volume":"17","author":"Pantano","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpba.2024.116100_bib8","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.toxrep.2021.09.003","article-title":"V.A: Boumba, Hair analysis for New Psychoactive Substances (NPS): Still far from becoming the tool to study NPS spread in the community?","volume":"8","author":"Florou","year":"2021","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.jpba.2024.116100_bib9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/1570159X15666161111112545","article-title":"Recent trends in analytical methods to determine new psychoactive substances in hair","volume":"15","author":"Kyriakou","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpba.2024.116100_bib10","article-title":"Comprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy","author":"La Maida","year":"2023","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.jpba.2024.116100_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.forsciint.2011.10.011","article-title":"Hair and urine testing to assess drugs of abuse consumption in couples undergoing assisted reproductive technology (ART)","volume":"218","author":"Pichini","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116100_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/biology10050403","article-title":"Hair testing for classic drugs of abuse to monitor cocaine use disorder in patients following transcranial magnetic stimulation protocol treatment","volume":"10","author":"Rotolo","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.jpba.2024.116100_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2023.111855","article-title":"Disappearance of codeine, morphine and 6-MAM in hair after cessation of abuse","volume":"352","author":"Su\u00e1rez-Garc\u00eda","year":"2023","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116100_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jat\/bkx020","article-title":"Hair Testing for Drugs of Abuse and New Psychoactive Substances in a High-Risk Population","volume":"41","author":"Salomone","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116100_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.011","article-title":"Prevalence of new psychoactive substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs: a cross sectional study by hair testing (2012-2017)","volume":"204","author":"Larabi","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jpba.2024.116100_bib16","series-title":"Hair Analysis in Clinical and Forensic Toxicology","first-page":"141","article-title":"Clinical applications of hair analysis","author":"Kintz","year":"2015"},{"key":"10.1016\/j.jpba.2024.116100_bib17","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/dta.3515","article-title":"Hair testing applied to the assessment of in utero exposure to drugs: Critical analysis of 51 cases of the University Hospital of Verona","volume":"15","author":"Bertaso","year":"2023","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116100_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/ph15030382","article-title":"Prevalence of licit and illicit drugs use during pregnancy in mexican women","volume":"15","author":"G\u00f3mez-Ruiz","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jpba.2024.116100_bib19","article-title":"Synthetic cannabinoids in hair-prevalence of use in abstinence control programs for driver's license regranting in Germany","author":"Kutzler","year":"2023","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116100_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jat\/bkac024","article-title":"LC-MS-MS determination of 88 psychotropic drugs in 1,865 hair samples from addicts in drug abstinence","volume":"47","author":"Ji","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116100_bib21","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1093\/jat\/bkac093","article-title":"A new multi-analyte LC-MS-MS screening method for the detection of 120 NPSs and 49 drugs in hair","volume":"46","author":"Rubicondo","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116100_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/dta.1640","article-title":"Workplace drug testing in Italy: findings about second-stage testing","volume":"7","author":"Vignali","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116100_bib23","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/imj.13975","article-title":"When should the driver with a history of substance misuse be allowed to return to the wheel? A review of the substance misuse section of the Australian national guidelines","volume":"48","author":"Ogden","year":"2018","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.jpba.2024.116100_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jflm.2023.102636","article-title":"A comprehensive LC-MS\/MS method for simultaneous analysis of 65 synthetic cannabinoids in human hair samples and application to forensic investigations","volume":"101","author":"Yang","year":"2024","journal-title":"J. Forensic Leg. Med."},{"key":"10.1016\/j.jpba.2024.116100_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jat\/bkx077","article-title":"Is hair analysis useful in postmortem cases?","volume":"42","author":"H\u00f8iseth","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116100_bib26","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/1556-4029.15348","article-title":"Detection of fentanyl, synthetic opioids, and ketamine in hair specimens from purposive samples of American and Italian populations","volume":"68","author":"Salomone","year":"2023","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.jpba.2024.116100_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.legalmed.2023.102325","article-title":"Uncovering forensic evidence of drug-facilitated sexual assault: Toxicological findings from Eastern Denmark from 2015-2022","volume":"65","author":"Skov","year":"2023","journal-title":"Leg. Med. (Tokyo)."},{"key":"10.1016\/j.jpba.2024.116100_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-4347(98)00010-3","article-title":"Quality control in toxicological analysis","volume":"713","author":"Ferrara","year":"1998","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jpba.2024.116100_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.forsciint.2004.04.025","article-title":", HAIRVEQ: an external quality control scheme for drugs of abuse analysis in hair","volume":"145","author":"Pichini","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116100_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/FTD.0b013e31802bb100","article-title":"Four years' experience in external proficiency testing programs for hair testing of drugs of abuse in Italy (HAIRVEQ) and comparison with the Society of Hair Testing program in 2005","volume":"29","author":"Ventura","year":"2007","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.jpba.2024.116100_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.forsciint.2007.06.022","article-title":"HAIRVEQ 2006: evolution of laboratories' performance after different educational actions","volume":"176","author":"Ventura","year":"2008","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116100_bib32","first-page":"144","article-title":"The complex and constantly evolving public health threat of new psychoactive substances in Italy: addressing the main functions of a national observatory of drugs","volume":"57","author":"Graziano","year":"2021","journal-title":"Ann. Ist. Super."},{"key":"10.1016\/j.jpba.2024.116100_bib33","unstructured":"Linee guida per la determinazione delle sostanze d\u2019abuso nella matrice pilifera 2010. Avallabile online https:\/\/www.iss.it\/documents\/20126\/0\/Linee_Guida_Capelli_xweb.pdf\/e24945df-c05a-73a8\u2013413a-7fbd321c6dad?t=1674665647006 (accessed 26 february 2024)."},{"key":"10.1016\/j.jpba.2024.116100_bib34","doi-asserted-by":"crossref","unstructured":"ScientificWorking Group for Forensic Toxicology (SWGTOX). Standard practices for method validation in forensic toxicology. J. Anal. Toxicol. 37 (2013) 452\u2013474.","DOI":"10.1093\/jat\/bkt054"},{"key":"10.1016\/j.jpba.2024.116100_bib35","unstructured":"International Conference on Harmonisation. ICH guideline M10 on bioanalytical method validation and study sample analysis. Available online https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf (accessed on 27 february 2024)."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T20:05:13Z","timestamp":1715285113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524001407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":34,"alternative-id":["S0731708524001407"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116100","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NPS\u2013EQA PART II: Four years\u2019 experience in external quality assessment program in Italy for classical and new psychoactive substances analysis in hair","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116100"}}